Feedback / Questions
CK0804 - Cellenkos
https://www.prnewswire.com/news-releases/fda-grants-orphan-drug-designation-to-cellenkos-ck0804-treg-therapy-for-treatment-of-myelofibrosis-302653827.html
Jan 6, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next